Browsing Tag
NASDAQ
806 posts
What does LifeVantage Corporation’s CEO appointment signal about the company’s real priorities in 2026?
LifeVantage has named Terrence Moorehead as CEO effective August 5, 2026. Read what the move signals for LFVN strategy, growth, and investor outlook.
April 19, 2026
Oportun Financial Corporation (NASDAQ: OPRT) appoints Doug Bland as CEO for next growth phase
Oportun Financial has named Doug Bland as chief executive officer. Read what the leadership shift could mean for growth, credit discipline, and OPRT stock.
April 19, 2026
SunOpta’s buyout just cleared a major hurdle. Is there anything left that can stop Refresco now?
SunOpta shareholders approved Refresco’s $6.50-per-share buyout. Read what the vote means, what risks remain, and what happens before closing.
April 19, 2026
Faraday Future and AIxCrypto-linked investor amend $12m pact to test real-world asset tokenization model
AIxCrypto and Faraday Future have amended a $12 million investment deal with a milestone warrant and tokenization angle. Read what it means now.
April 19, 2026
Payward’s Bitnomial acquisition shows Kraken is building infrastructure, not just buying growth
Kraken parent Payward is buying Bitnomial for up to $550 million. Read why this deal matters for U.S. crypto derivatives and market structure.
April 18, 2026
Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
Kailera Therapeutics priced its IPO at $16 to raise $625M. Read what the deal means for KLRA, obesity drug competition, and biotech funding now.
April 18, 2026
What Alamar Biosciences’ (NASDAQ: ALMR) IPO pop says about the next phase of proteomics investing
Alamar Biosciences surged after its upsized IPO. Read what the debut means for proteomics, public markets, and life science tools investors.
April 18, 2026
Why Cerebras’ IPO filing looks less like a chip listing and more like an AI infrastructure wager
Cerebras has filed for an IPO after a massive OpenAI deal. Read why the filing matters for AI chips, inference economics, and public market appetite.
April 18, 2026
PepsiCo (PEP) beats Q1 2026 earnings estimates as Frito-Lay volumes return to growth after price cuts
PepsiCo beat Q1 2026 estimates with $1.61 core EPS and $19.4B revenue as Frito-Lay volumes inflected. Full-year guidance affirmed. Read the full analysis.
April 17, 2026
Why Jane Street’s $7bn CoreWeave bet could reshape AI infrastructure demand in finance
Jane Street’s $6 billion CoreWeave cloud deal and $1 billion stock buy could reshape AI infrastructure demand in finance. Read the deeper strategic story.
April 16, 2026